Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i vs Tempus ECG-AF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Canon Medical Systems Corporation
VS
by Tempus AI, Inc.

AI Verdict

These tools are adjacent in the Cardiology AI space, but serve distinct functions. Tool A, the Aquilion Prime SP, is a CT scanner leveraging AI for superior image quality and dose optimization across various imaging needs, including cardiology. In contrast, Tool B, Tempus ECG-AF, is a software-based algorithm designed to predict the risk of atrial fibrillation from 12-lead ECGs in specific patient populations.

Choose Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i if…

Choose the Aquilion Prime SP if your facility requires a versatile, high-performance CT scanner capable of delivering superior image quality across a wide range of clinical applications, including advanced cardiology, oncology, and emergency medicine. It is ideal for detailed anatomical imaging, dose-sensitive patients, and situations demanding rapid scanning with deep learning reconstruction for optimal diagnostic confidence.

View Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i →

Choose Tempus ECG-AF if…

Choose Tempus ECG-AF if your objective is to proactively identify elderly patients (65+) at increased risk of developing new-onset atrial fibrillation within the next year, enabling earlier intervention and management. This software solution is best suited for integrating into routine cardiology, geriatrics, or internal medicine workflows to enhance risk stratification based on standard 12-lead ECGs.

View Tempus ECG-AF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i Tempus ECG-AF
Pricing Contact vendor for pricing Contact vendor
Deployment On-premise (CT scanner), also available in modular or mobile setups Software solution, integrated into healthcare facility systems with advanced cardiology algorithms.
BAA Available Unknown Yes AI-estimated
FDA Status Yes AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools aim to optimize their respective workflows. Tool A, as a complex hardware system, emphasizes AI-assisted imaging and optimized workflow for its operators. Tool B, a software solution, relies on seamless integration with existing systems and clear presentation of its AI-driven insights. Without specific UI/UX details for either, it's difficult to definitively declare one superior in overall usability.

Clinical Value

Tie

Both tools offer significant and distinct clinical value. Tool A enhances the fundamental diagnostic capabilities of CT imaging across multiple specialties, improving image quality and patient safety. Tool B provides a novel, actionable predictive insight for a specific, high-risk patient population, enabling earlier intervention for a serious condition. Their value propositions are different but equally impactful in their respective domains.

Pricing & Value

Tempus ECG-AF

Tool B clearly wins in this dimension due to its transparency regarding reimbursement. The availability of established CMS reimbursement pathways (CPT 0764T and CPT 0765T) provides a clear financial model and reduces the financial risk for healthcare providers, making its value proposition more tangible compared to Tool A's completely opaque pricing.

Enterprise Readiness

Tempus ECG-AF

While both are FDA cleared and HIPAA compliant, Tool B, as a software solution, generally presents a lower barrier to enterprise adoption compared to a large capital equipment like a CT scanner. Its explicit compatibility with existing major ECG systems further enhances its readiness for seamless integration into diverse healthcare IT environments without requiring major physical infrastructure changes.

Innovation

Tempus ECG-AF

While both tools demonstrate strong innovation by leveraging AI, Tool B's innovation lies in creating a new, actionable predictive insight from existing diagnostic data (ECGs), which can lead to earlier intervention for a significant condition. Tool A's innovation primarily enhances the quality and safety of an existing imaging modality, which is impactful but arguably less disruptive in terms of generating entirely new clinical insights.

Support & Docs

Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i

Canon Medical Systems offers more comprehensive and continuous support, including 24/7/365 phone access and advanced remote diagnostic capabilities, which are critical for maintaining uptime for a complex medical device like a CT scanner. While Tempus AI offers support during business hours and a document library, its support structure appears less extensive and always-on compared to Canon's.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i Tempus ECG-AF
Product Name Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i Tempus ECG-AF
Company Canon Medical Systems Corporation Tempus AI, Inc.
Primary Function/Description CT scanner featuring Deep Learning Reconstruction (AiCE-i) for superior image quality, noise reduction, and dose optimization, offering comprehensive clinical capabilities. AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months.
Categories Cardiology AI, Oncology AI, Radiology & Imaging AI Cardiology AI
Specialties Cardiology, Oncology, Radiology Cardiology, Geriatrics, Internal Medicine
Key Technology/Methodology AiCE-i (Advanced intelligent Clear-IQ Engine - integrated) Deep Learning Reconstruction, 40-row CT System, PUREViSION Optics, SURECardio Helical Prospective, SEMAR. AI-based algorithm for 12-lead ECG analysis, trained on over 1.5 million ECGs from over 500,000 patients.

Videos

Demos, reviews, and walkthroughs featuring Aquilion Prime SP (TSX-303B8) V10.2 with AiCE-i and Tempus ECG-AF.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Aquilion Prime SP (Tool A) integrates directly into the CT scanning workflow, with its AiCE-i Deep Learning Reconstruction enhancing image acquisition. Tempus ECG-AF (Tool B) is a software solution that integrates into healthcare facility systems, analyzing 12-lead ECG recordings and is designed to work with existing ECG platforms and EHRs to enable advanced AI deployment and insights within clinical workflows.
The Aquilion Prime SP (Tool A) provides superior image quality, noise reduction, and dose optimization for diverse patient needs, aiding in confident clinical results across various applications. Tempus ECG-AF (Tool B) identifies patients aged 65 or older at increased risk of developing atrial fibrillation/flutter within 12 months, with a reported sensitivity of 31% and specificity of 92% for classifying patients who developed clinically recognized AF in the next year.
The Aquilion Prime SP (Tool A) is a versatile CT scanner suitable for Radiology, Cardiology, Oncology, and Emergency Medicine, accommodating patients from pediatric to bariatric. Tempus ECG-AF (Tool B) is specifically designed for Cardiology, Geriatrics, and Internal Medicine, focusing on patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery.
For the Aquilion Prime SP (Tool A), the AiCE-i Deep Learning Reconstruction is integrated into the CT system, meaning the primary learning curve for staff would be on operating the scanner, with physicians focusing on interpreting the enhanced image quality. For Tempus ECG-AF (Tool B), the learning curve for physicians involves understanding the AI-based risk assessment and incorporating its 'increased risk' or 'no increased risk' output into clinical decision-making and follow-up protocols.
The Aquilion Prime SP (Tool A) would typically maintain detailed logs of scan parameters, patient data, and radiation dose, providing an audit trail for imaging procedures. Tempus ECG-AF (Tool B), as a software solution, would likely feature audit trails for ECG analysis requests, the binary risk results, and user interactions to ensure transparency and accountability in its AI-generated insights.
A multi-site rollout of the Aquilion Prime SP (Tool A) would involve significant logistical planning for physical installation, environmental requirements, and network integration of the CT hardware at each facility. For Tempus ECG-AF (Tool B), multi-site deployment would focus on software integration with various existing ECG platforms and EHR systems across different facilities, requiring coordination of IT infrastructure and data flow.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.